April 29th 2021
ACP: Clyde W Yancy, MD, gave a comprehensive update on a year's worth of pivotal science in treatment of heart failure. Here are the highlights.
April 29th 2021
The NIAID head said the timing of the end of the pandemic is really up to the public.

April 29th 2021
Research shows that increased risk of chronic disease and mortality begins below a BMI classified as obesity. The earlier we intervene with at-risk patients, the greater the chance for success.
April 23rd 2021
For frontline clinicians who care daily for patients with obesity and type 2 diabetes, a weight-centric approach to T2D, including antiobesity drugs, could help improve outcomes.
April 23rd 2021
Long time cardiometabolic investigator Harold Bays, MD, talks about obesity, new drugs to treat the disease, and how the words "be inefficient" could change thinking about treatment.

April 22nd 2021
Primary care physicians face unique challenges when managing patients with obesity, but one obesity specialist aims to show clinicians how to meet them, even if it's in small ways.
April 22nd 2021
Citing a study of "The Biggest Loser" participants, obesity expert Dr Silvana Pannain explains why "Eat less, exercise more," often backfires as a sole intervention for persons with obesity.
April 19th 2021
Keith C Ferdinand, MD, discusses how deeply-rooted social determinants of health have led to the vastly disproportionate impact of COVID-19 on persons of color.

March 19th 2021
ENDO 2021: Fewer than 1-in-10 older adults with a hip fracture had been prescribed bone-directed treatment in the 6 months prior to the incident, according to research on trends in treatment.

June 19th 2020
VIDEO: Kieran Docherty, MBChB, discusses results of the DAPA-HF analysis on the impact of background T2D therapy on clinical outcomes in patients with T2D and HFrEF.